N/A
Manufactured by Micro Labs Limited
53,232 FDA adverse event reports analyzed
Last updated: 2026-04-15
PIROXICAM is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Micro Labs Limited. The most commonly reported adverse reactions for PIROXICAM include DRUG HYPERSENSITIVITY, RASH, ARTHRALGIA, CONDITION AGGRAVATED, DRUG INEFFECTIVE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for PIROXICAM.
Out of 6,175 classified reports for PIROXICAM:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 53,232 FDA FAERS reports that mention PIROXICAM. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include DRUG HYPERSENSITIVITY, RASH, ARTHRALGIA, CONDITION AGGRAVATED, DRUG INEFFECTIVE, RHEUMATOID ARTHRITIS. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Micro Labs Limited in connection with PIROXICAM. Always verify the specific product and NDC with your pharmacist.